retatrutide trial duration just delivered the most powerful weight loss data ever recorded in a Phase 3 obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Eli Lilly's Phase 3 clinical

Common Side Effects to Consider GLP-1 medications are generally well tolerated, but side effects are common, particularly as the dose is gradually increased to the target level

Bupropion may increase dopamine-mediated testosterone activity, while rapid weight loss from tirzepatide affects testosterone levels through changes in fat tissue aromatase activity and sex hormone binding globulin levels

The main endogenous source of CO is heme metabolism by heme-oxygenase (HO) [8, 9]

For individuals with Type 2 Diabetes, where elevated blood glucose levels are common, GLP-1 and GLP-2 effectively reduces these levels

Before starting treatment, talk with your doctor and pharmacist